The Week Ahead: COS...
Health Care: Drugs
Neuralstem Inc. (CUR: AMEX)
$1.40 -0.04 | -2.78%
05/24/13 - 04:00 PM ET
Portfolios with CUR
- Portfolio NameUser Type
- Userdennis diamonds
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Usermine
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBio
- Userjustin
- ContributorBreakout Stocks Of The Week...
Latest CUR Headlines from TheStreet
- 5 Stocks Under $10 Set to Soar 05.09.13 | 01:05 pm
- 4 Biotech Stocks Under $10 Moving Higher 11.27.12 | 02:11 pm
- 4 Biotech Stocks Under $10 Moving Higher 10.05.12 | 08:10 am
- Stocks Close Week Higher on QE3 Confidence 09.14.12 | 05:09 pm
- 5 Stocks Under $10 Setting Up to Break Out 09.13.12 | 12:09 pm
- 5 Stocks Poised for Big Breakouts 08.31.12 | 01:08 pm
- 9 Biotech Penny Stocks to Buy 08.31.10 | 10:08 am
- Interstate Hotel, Neuralstem: Midday Volume Plays 12.18.09 | 01:12 pm
- Four Must-See Charts: Stem Cell Stocks 07.02.09 | 03:07 pm
- Stem cell firms jump on Obama policy plans 03.06.09 | 06:03 pm
Press Releases for CUR
- Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International Convention - PR Newswire 04.18.13 | 09:04 am
- Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral Sclerosis - PR Newswire 04.17.13 | 08:04 am
- Nominations Pursuant To Advance Notice Policy - PR Newswire 04.15.13 | 07:04 am
- DiagnoCure's Adoption Of An Advance Notice Policy - PR Newswire 04.09.13 | 08:04 am
- Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis - PR Newswire 04.05.13 | 09:04 am
- DiagnoCure Joins The OTCQX Marketplace And S&P Corporation Records Listing - PR Newswire 04.02.13 | 07:04 am
- DiagnoCure Begins Trading On OTCQX® - PR Newswire 04.02.13 | 07:04 am
- Neuralstem Secures $8 Million In Debt Financing From Hercules - PR Newswire 03.25.13 | 09:03 am
- Neuralstem CEO, Richard Garr, Named To "Top 50 Global Stem Cell Influencers" - PR Newswire 03.14.13 | 09:03 am
- Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center - PR Newswire 02.20.13 | 09:02 am
Partner Headlines for CUR
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
- 3 Regenerative Medicine Companies That Could Deliver In 2013 - Seeking Alpha 01.22.13 | 09:01 am
- Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned - Seeking Alpha 12.16.12 | 08:12 am
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- 4 Biotechs That Just Got Mauled By Bears - Seeking Alpha 10.10.12 | 09:10 am
- Morning Market Movers - Benzinga 10.04.12 | 09:10 am
- Dr. Eva Feldman, Principal Investigator, To Update Interim Data On Neuralstem ALS Trial - Benzinga 10.04.12 | 09:10 am
- Neuralstem Grants First Licenses for CNS Therapy Surgical Devices - Benzinga 09.06.12 | 09:09 am
- ALS Patient's Survival is "One of the Most Powerful Stories" Ever Reported - Benzinga 08.27.12 | 01:08 pm
- End-of-Day Market Summary for November 23, 2011 - Benzinga 11.23.11 | 04:11 pm
